Detalhe da pesquisa
1.
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Blood;
137(23): 3237-3250, 2021 06 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33512451
2.
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.
Lancet Oncol;
21(11): 1433-1442, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33035457
3.
Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Blood;
132(12): 1318-1331, 2018 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29914977
4.
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
J Clin Oncol;
42(14): 1612-1618, 2024 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38364196
5.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
J Clin Oncol;
41(19): 3523-3533, 2023 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37071836
6.
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.
Lancet Haematol;
10(1): e59-e70, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36493799
7.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Blood Adv;
7(16): 4435-4447, 2023 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37276067
8.
ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.
Clin Lymphoma Myeloma Leuk;
17(6): 362-369.e2, 2017 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28622961